University of Tokyo, Vedanta, accuse 'Vowst' microbiota by Seres, Nestlé, of infringing five US patents
The University of Tokyo and Vedanta Biosciences say a series of patents relating to the promotion of T-cell growth are infringed by Seres Therapeutics and Nestlé Health Science’s microbiota “Vowst.” A...To view the full article, register now.
Already a subscriber? Click here to view full article